Upstate Medical University

Category Archives: Uncategorized

  1. New Flu Vaccine

    Dr. Stephen Thomas, Upstate Global Health Institute Director, talks new flu vaccine.

  2. Meet you Doctor – Stephen Thomas, M.D

    SUNY Upstate physician discusses the work of the Global Health Institute and how it’s helping advance research on infectious diseases and vaccines

  3. How to protect chickens — and yourself — from avian flu

    Elizabeth Asiago-Reddy, MD, discusses ways to protect yourself and your flock of chickens, and why bird flu is such a concern.

  4. Upstate enrolling seniors in landmark C. diff vaccine study

  5. Dr Stephen Thomas named interim vice president for research

    Stephen Thomas,MD, the Frank E. Young, MD, and Leanne Young Endowed Chair of Microbiology and Immunology and Director of the Global Health Institute, has been named interim vice president for research.

  6. Upstate helps lead global trial that could change heart failure care

    Upstate Medical University has enrolled the first patient in a landmark international clinical trial that could reshape treatment for heart failure patients with cardiomyopathy and electrical conduction issues

  7. Central New York teens take part in clinical study for Lyme disease vaccine

  8. Six Honored with Gold Standard Awards

    Upstate Medical University has selected six faculty members as Gold Standard Award winners. The awards recognize individuals for work exemplifying the missions of Upstate, with particular emphasis on professionalism, work ethic and character.

  9. Human Challenge Models: A New Gold Standard?

    Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard for establishing efficacy and safety at the World Vaccine Congress Washington 2026.

  10. Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

    There are currently no approved human vaccines for Lyme disease, and PF-07307405 is the Lyme disease vaccine candidate which has currently advanced the furthest along the clinical development timeline, with two pivotal Phase 3 trials completed.